BIOLOGICS RARE AND ORPHAN CARE Trademark

Trademark Overview


On Friday, January 22, 2021, a trademark application was filed for BIOLOGICS RARE AND ORPHAN CARE with the United States Patent and Trademark Office. The USPTO has given the BIOLOGICS RARE AND ORPHAN CARE trademark a serial number of 90482182. The federal status of this trademark filing is REGISTERED as of Tuesday, February 15, 2022. This trademark is owned by McKesson Corporation. The BIOLOGICS RARE AND ORPHAN CARE trademark is filed in the Medical & Beauty Services & Agricultural Services, Personal and Legal & Social Services categories with the following description:

Providing patient case management assistance services, namely, coordinating the procurement and administration of complex and high-cost rare and orphan specialty medications

Dispensing of pharmaceuticals in the rare and orphan therapeutic areas; providing pharmaceutical advice in the field of delivery of oncology and rare and orphan drugs; medical counseling, namely, counseling for patients with cancer and other rare and orphan conditions to ensure safety and compliance in taking oncology and other highly complex rare specialty drugs; dispensing of pharmaceuticals in oncology and other rare and orphan therapeutic fields; dispensing of medications; consulting services in the field of health provided to clinicians, biopharma, life science companies, researchers and payors to help monitor and achieve positive outcomes for patients
biologics rare and orphan care

General Information


Serial Number90482182
Word MarkBIOLOGICS RARE AND ORPHAN CARE
Filing DateFriday, January 22, 2021
Status700 - REGISTERED
Status DateTuesday, February 15, 2022
Registration Number6648633
Registration DateTuesday, February 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding patient case management assistance services, namely, coordinating the procurement and administration of complex and high-cost rare and orphan specialty medications
Goods and ServicesDispensing of pharmaceuticals in the rare and orphan therapeutic areas; providing pharmaceutical advice in the field of delivery of oncology and rare and orphan drugs; medical counseling, namely, counseling for patients with cancer and other rare and orphan conditions to ensure safety and compliance in taking oncology and other highly complex rare specialty drugs; dispensing of pharmaceuticals in oncology and other rare and orphan therapeutic fields; dispensing of medications; consulting services in the field of health provided to clinicians, biopharma, life science companies, researchers and payors to help monitor and achieve positive outcomes for patients
Disclaimer with Predetermined Text"BIOLOGICS RARE AND ORPHAN"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code044
First Use Anywhere DateFriday, July 31, 2020
First Use In Commerce DateSunday, January 31, 2021

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code045
First Use Anywhere DateFriday, July 31, 2020
First Use In Commerce DateSunday, January 31, 2021

Trademark Owner History


Party NameMcKesson Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Party NameMcKesson Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Trademark Events


Event DateEvent Description
Tuesday, February 15, 2022REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, January 12, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 12, 2022ASSIGNED TO LIE
Tuesday, January 11, 2022APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, January 11, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Saturday, January 8, 2022USE AMENDMENT ACCEPTED
Saturday, November 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 20, 2021AMENDMENT TO USE PROCESSING COMPLETE
Saturday, November 20, 2021USE AMENDMENT FILED
Friday, November 19, 2021TEAS AMENDMENT OF USE RECEIVED
Wednesday, May 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION WRITTEN
Friday, May 14, 2021ASSIGNED TO EXAMINER
Friday, April 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 26, 2021NEW APPLICATION ENTERED IN TRAM